Biomedical Sciences
Global

Biomedical Sciences Experts

Rowland

Independent Consultant
Board
Nabriva Therapeutics
Austria

Biography

He is a member of the board of directors of Blueprint Pharmaceuticals. He was most recently the CEO of Aurinia Pharmaceuticals. He was previously the VP and CFO of ViroPharma Inc., until it was acquired by Shire plc in January 2014. He has over 35 years of diversified experience in pharmaceutical operations and all areas of finance and accounting. Prior to joining ViroPharma in 2008, he was EVP and CFO, for Endo Pharmaceuticals, as well as, interim Co-CEO. Charles held positions of increasing responsibility at Biovail Corporation, Breakaway Technologies, Pharmacia Corporation, Novartis AG and Bristol-Myers Squibb Co. He holds an MBA from Rutgers University and a BS in Accounting from Saint Joseph's University.

Research Interest

Pharmaceutics.

Global Experts from Austria

Global Experts in Subject